Komentarai Siųsti draugui Spausdinti Vertinimas Neįvertintas

GRD: „Grindeks” emphasizes, that the price of the Mildronate in Latvia is smaller than in other countries

Spekuliantai.lt | 2009-09-21 | NASDAQ OMX biržų naujienos | perskaitė: 1322
Raktiniai žodžiai: Grindeks, GRD
GRD: „Grindeks” emphasizes, that the price of the Mildronate in Latvia is smaller than in other countries

Grindeks Company Announcement 21.09.2009

„Grindeks” emphasizes, that the price of the Mildronate in Latvia is smaller
than in other countries

JSC „Grindeks” objects to the broadcasted information by “Nekā Personīga” on
TV3, on September 20, 2009, that the price of the Mildronate in Latvia is
double compared to price in other countries.

„Grindeks” takes notice, that for Latvian market Mildronate 250mg 40 capsules
packages are not produced. The TV broadcast absolutely inconsiderately compared
the price for 40 capsules packages in Ukraine with the price for Mildronate
250mg 60 capsules packages in Latvia. This is the main factor, which makes the
difference. The other factor - in Ukraine medications are not imposed by Value
added tax (VAT), conversely for medication in Latvia are applied 10% VAT rate.

„Grindeks” informs, that Mildronate 250mg 40 capsules package declared sales
price for the Ukraine market is 3,16 lats for the package, whereas for Latvian
wholesalers - 4,45 lats for Mildronate 250mg 60 capsule package.

Comparing in such a way the price of one Mildronate capsule in Ukraine is 0,079
lats, but in Latvia is 0,074 lats.

About “Grindeks”
“Grindeks” is the leading pharmaceutical company in the Baltic States. The main
directions of its operation are research, development, manufacturing and sales
of original products, as well as generics and active pharmaceutical
ingredients. “Grindeks” specializes in the heart and cardiovascular,
psychotropic and anti-cancer therapeutic groups of medications.
„Grindeks” concern consists of four subsidiary companies in Latvia, Estonia and
Russia; as well as representatives and representative offices in 14 countries.
Products of the company are exported to more than 40 countries and its export
comprises more than 96% of the total turnover. The main markets are the Baltic
States, Russia and other CIS countries, as well as Japan and USA. The shares of
JSC „Grindeks” are listed in the Official List of „NASDAQ OMX Riga”.
Further information:

Laila Kļaviņa
Head of the Communications Department
JSC “Grindeks”
E-mail: laila.klavina@ grindeks.lv
Phones: +371 67083370, +371 29256012

Taip pat skaitykite

DPK: Decisions of the regular meeting of shareholders dated 27.05.2013

VLN: NEW MUTUAL FUND TO THE BALTIC FUND CENTER

VLN: The results of the primary placement auction of Lithuanian Government securities

VLN: VVP pirminio platinimo aukciono rezultatai

2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos 2013-05-27 | NASDAQ OMX biržų naujienos

Komentarai



Ekonominis kalendorius

Prekybos statistika realiu laiku

Techninės analizės įrankis

Privatumo politika Reklama Kontaktai Paskolos RSS RSS
© 2006-2024 UAB All Media Digital